I

iBio
D

IBIO

3.06000
USD
0.20
(6.99%)
مغلق
حجم التداول
25,844
الربح لكل سهم
-2
العائد الربحي
-
P/E
-12
حجم السوق
28,734,248
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    -0.04500
    (-0.87%)
    5.14000 USD
    A
    ACRS
    0.00000
    (0.00%)
    2.58500 USD
    A
    ADAP
    -0.00560
    (-0.97%)
    0.57280 USD
    A
    ADC
    -1.680
    (-2.30%)
    71.510 USD
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    B
    BCLI
    -0.17000
    (-7.39%)
    2.13000 USD
    A
    ATYR
    -0.11500
    (-3.18%)
    3.50500 USD
    المزيد
الأخبار
المقالات

العنوان: iBio

القطاع: Healthcare
الصناعة: Biotechnology
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.